Capital Signal

Cyclopharm Limited (ASX: CYC)

Sector: Health Care

Market cap: A$53M (as of 2 Nov 2026)

The Company produces and supplies the medical profession with proprietary lung radiopharmaceuticals.

Data as of 2 Nov 2026.

Recent capital raises

DateTypeAmountPriceDiscountSource
9 Mar 2026SPP$0.183M$0.95—Filing ↗
24 June 2024SPP$4M$1.42—Filing ↗
17 Feb 2021SPP$3M$2.60—Filing ↗
19 Dec 2019Placement$9.78M$1.1511.7% premiumFiling ↗

Substantial holders — latest moves

DateHolderMoveHoldingSource
12 Oct 2026State Street Australia Ltd ACF Australian Ethical Investment LimitedDecrease8.88% → 7.78%Filing ↗
25 June 2026REGAL FUNDS MANAGEMENT PTY LIMITED AND ASSOCIATESDecrease11.310% → 9.870%Filing ↗
21 Apr 2026Barrings Acceptance LimitedIncrease10.573% → 13.718%Filing ↗
28 Jan 2025Australian Ethical Investment LimitedDecrease10.040% → 8.880%Filing ↗
10 June 2024ANGLO AUSTRALIAN CHRISTIAN AND CHARITABLE FUNDDecrease14.390% → 12.200%Filing ↗

Director trades — on-market

DateDirectorTradeSource
26 Feb 2025John William WigglesworthBought 13,500Filing ↗
26 Feb 2025David James HeaneyBought 8,874Filing ↗
30 Sept 2024John William WigglesworthBought 33,000Filing ↗
3 June 2024Gregory George KingBought 10,000 sharesFiling ↗
29 May 2024John William WigglesworthBought 20,979 sharesFiling ↗

Ask about CYC in Claude or ChatGPT

Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:

  • Has CYC raised money in the last year, and at what discount?
  • What was CYC's latest cash position and runway?

Setup guide for Claude, ChatGPT and other MCP clients →

Loading CYC…

Cyclopharm Limited (ASX: CYC): capital raises, holders, director trades | Capital Signal